About Paragon Biosciences
Paragon Biosciences is a company based in Chicago (United States) founded in 2010 by Jeffrey S Aronin. Paragon Biosciences has raised $311.6 million across 7 funding rounds. Paragon Biosciences offers products and services including Innovative Therapies and Regenerative Medicines.
- Headquarter Chicago, United States
- Founders Jeffrey S Aronin
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paragon Biosciences Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$311.6 M (USD)
in 7 rounds
-
Latest Funding Round
$185 M (USD), Series E
Nov 09, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paragon Biosciences
Paragon Biosciences offers a comprehensive portfolio of products and services, including Innovative Therapies and Regenerative Medicines.
Innovative therapies for patients with rare neurological diseases are developed and commercialized by the company.
Regenerative medicines that restore function for severe skin and connective tissue disorders are developed.
People of Paragon Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Paragon Biosciences
Paragon Biosciences has successfully raised a total of $311.6M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $185 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Paragon Biosciences
Investment portfolio details for Paragon Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Paragon Biosciences
Detailed financials for Paragon Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paragon Biosciences Comparisons
Peer comparison for Paragon Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paragon Biosciences
Detailed competitors of Paragon Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paragon Biosciences
Complete news archive for Paragon Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragon Biosciences
Paragon Biosciences was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Paragon Biosciences is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Jeffrey S Aronin is the current CEO of Paragon Biosciences. They have also founded this company.
Paragon Biosciences is a funded company, having raised a total of $311.6M across 7 funding rounds to date.
Paragon Biosciences was founded in 2010 and is headquartered in Chicago, United States. Operations focus on the healthcare sector, where advisory services are offered to companies seeking strategic guidance. The firm is led by Jeffrey S. Aronin as founder and CEO. Expertise is applied across various healthcare subsectors, supporting decision-making and growth initiatives within the industry.
Paragon Biosciences offers Innovative Therapies and Regenerative Medicines.